Anti-placental growth factor monoclonal antibody

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAnti-placental growth factor monoclonal antibody
Drug Alias NameๆŠ—่ƒŽ็›˜็”Ÿ้•ฟๅ› ๅญๅ•ๅ…‹้š†ๆŠ—ไฝ“Anti-PlGFAnti-PlGF monoclonal antibodyTHR-317R-7334 +[9]ย 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlacental Growth Factor inhibitorsAngiogenesis inhibitors
TargetsPlacental Growth Factor
Therapy Area/IndicationsSolid tumoursDiabetes MellitusRetinal Telangiectasis +[11]ย 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumSlovakia +[11]ย 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsMacular DegenerationMedulloblastoma
Inactive IndicationsSolid tumoursDiabetes MellitusRetinal Telangiectasis +[9]ย 

Other Information

ATC CodeN/A
Related LinksN/A